Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE: 603882)
Health Care · Health Care Providers & Services · CN
CN¥28.82
-0.83% today · -0.7% 1Y
Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE: 603882) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.96B and employs 9,529 people.
Over the last twelve months the share price has lost 0.7%, trading between 21.50 and 40.68.
Tweenvest scores Guangzhou Kingmed Diagnostics Group Co., Ltd. across four factors: quality 68/100, value 49/100, growth 8/100, dividend 74/100. Its strongest factor is dividend.
603882 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.96B
- Revenue (TTM)
- $871.19M
- P/E
- 131.59
- EPS
- 0.22
- Dividend yield
- 3.05%
- Beta (5Y)
- 0.37
- 52-week high
- CN¥40.68
- 52-week low
- CN¥21.50
- Avg volume (3M)
- —
- Shares outstanding
- 456.64M
- Employees
- 9,529
- Next earnings
- —
About Guangzhou Kingmed Diagnostics Group Co., Ltd.
Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a prominent independent medical laboratory provider. Its extensive service portfolio encompasses a wide array of offerings, such as medical diagnostic information, clinical trial assistance, and comprehensive laboratory services. The company also specializes in food and hygiene testing, health management solutions, and medical cold chain logistics. Additionally, Kingmed engages in scientific research, develops in vitro diagnostics, and utilizes advanced capabilities in healthcare big data, artificial intelligence, and forensic testing. Operating a network of 37 state-of-the-art testing facilities, the company maintains a significant presence across both mainland China and Hong Kong. Established in 2003, its corporate headquarters are situated in Guangzhou, China.
- ISIN
- CNE100002VW1
- Founded
- 2006
- Listed since
- Sep 8, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Addus HomeCare CorporationNasdaqGS: ADUS | $2.09B | $116.79 | +2.15% |
| China Meheco Group Co., Ltd.SHSE: 600056 | $2.04B | CN¥9.14 | +2.93% |
| Qingdao Baheal Medical INC.SZSE: 301015 | $2.04B | CN¥25.94 | +1.01% |
| GeneDx Holdings Corp.NasdaqGS: WGS | $2.01B | $66.21 | -1.66% |
| Astrana Health, Inc.NasdaqCM: ASTH | $1.92B | $38.21 | +1.76% |
| Huaxia Eye Hospital Group Co.,Ltd.SZSE: 301267 | $1.88B | CN¥15.16 | +0.66% |
| Dian Diagnostics Group Co.,Ltd.SZSE: 300244 | $1.86B | CN¥20.40 | -0.58% |
| Fagron NVENXTBR: FAGR | $1.82B | €22.35 | +0.68% |
Figures last refreshed Oct 11, 2026.